KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teradyne (TER) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Teradyne (TER) over the last 17 years, with Q3 2025 value amounting to $49.0 million.

  • Teradyne's Cash from Operations fell 7050.0% to $49.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $675.3 million, marking a year-over-year increase of 578.54%. This contributed to the annual value of $672.2 million for FY2024, which is 1485.65% up from last year.
  • As of Q3 2025, Teradyne's Cash from Operations stood at $49.0 million, which was down 7050.0% from $182.1 million recorded in Q2 2025.
  • In the past 5 years, Teradyne's Cash from Operations ranged from a high of $522.7 million in Q4 2021 and a low of $7.3 million during Q1 2024
  • In the last 5 years, Teradyne's Cash from Operations had a median value of $174.3 million in 2023 and averaged $175.1 million.
  • Its Cash from Operations has fluctuated over the past 5 years, first tumbled by 8043.47% in 2022, then surged by 212059.35% in 2025.
  • Quarter analysis of 5 years shows Teradyne's Cash from Operations stood at $331.3 million in 2021, then tumbled by 44.64% to $183.4 million in 2022, then skyrocketed by 35.65% to $248.8 million in 2023, then grew by 13.58% to $282.6 million in 2024, then plummeted by 82.64% to $49.0 million in 2025.
  • Its Cash from Operations stands at $49.0 million for Q3 2025, versus $182.1 million for Q2 2025 and $161.6 million for Q1 2025.